dr. bastholt on lenvatinib in thyroid cancer
Published 7 years ago • 596 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
0:58
dr. bastholt on lenvatinib in nsclc
-
1:28
dr. wirth on the use of lenvatinib in hypertensive patients with thyroid cancer
-
1:59
dr. cohen on lenvatinib in first- or second-line thyroid cancer
-
2:47
dr. brose discusses lenvatinib and sorafenib in differentiated thyroid cancer
-
1:23
dr. brose discusses lenvatinib for the treatment of patients with thyroid cancer
-
1:10
dr. marcia brose on lenvatinib in differentiated thyroid cancer
-
1:39
pembrolizumab/lenvatinib combo achieves promising responses in anaplastic thyroid cancer
-
1:00:02
papillary thyroid cancer in children & young adults: retrospective study with dr. wang
-
1:40
phase ii trial of lenvatinib for anaplastic thyroid cancer
-
6:47
lenvatinib: new kid on the block
-
0:48
dr. cabanillas on lenvatinib as first-line therapy for patients with dtc
-
1:00
lenvatinib in thyroid cancer with and without vegf-targeted therapy
-
1:03
jena d. french on anti-pd-1/lenvatinib combo in differentiated thyroid cancer
-
1:17
dr. marcia brose discusses lenvatinib as a new option in dtc
-
0:57
dr. taylor discusses the toxicities and impact of lenvatinib in the select trial
-
1:00:47
optimizing treatment in differentiated thyroid cancer with dr. newbold
-
6:53
sequencing in dtc: lenvatinib and sorafenib
-
59:27
combination of lenvantinib and pembrolizumab for thyroid cancer with dr. bryan haugen
-
1:46
dr. bible on impact of lenvatinib on treatment landscape of dtc